Enodia Therapeutics
FranceEntry
2026
Hold
New
Status
Active
Who owns Enodia Therapeutics?
Enodia Therapeutics is currently owned by Elaia Partners through DTS3 (2024 vintage), since 2026. Across its history, Enodia Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Ownership history
2 ownership periods
Active
Lazard Elaia CapitalActive
2026 · present(<1yr) · Elaia Legacy Fund · 2002 · VC
Elaia PartnersActive
2026 · present(<1yr) · DTS3 · 2024 · VC
More from DTS3
Other portfolio companies in the same fund.
US
Germany
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Enodia Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Enodia Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue